학술논문
A Phase I Randomized Study of a Specifically Engineered, pH-Sensitive PCSK9 Inhibitor RN317 (PF-05335810) in Hypercholesterolemic Subjects on Statin Therapy
Document Type
Article
Author
Source
In: Clinical and Translational Science . (Clinical and Translational Science, 1 January 2017, 10(1):3-11)
Subject
Language
English
ISSN
17528062
17528054
17528054